(NASDAQ:SRPT), SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025. Sarepta is a commercial-stage biopharmaceutical company that focuses on RNA and gene therapies […]

Sarepta Therapeutics, Inc. Class Action Notice: Robbins LLP Reminds SRPT Stockholders of the Lead Plaintiff Deadline in the SRPT Class Action Lawsuit GlobeNewswire July 03, 2025 SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Sarepta Therapeutics,

A “Must Attend” for Potential Homeschoolers Accredited schools and leading curriculum providers from across the country are visiting Kansas City for Acellus World, a family-fun educational extravaganza. Taking place July 10-12 from 9:00 AM to 10:00 PM at the new Acellus Conference Center, Acellus World aims to be the largest digital learning event in the

(TSX:ORA),(Bovespa:AURA33.SA),(OTC US:ORAAF),(Other OTC:ORAAF),(Bovespa:AURA33), ROAD TOWN, British Virgin Islands, July 03, 2025 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to announce Q2 2025 preliminary production results from the Company's operating mines: Aranzazu, Apoena, Minosa, Almas and Borborema. Total production in Q2 2025 reached 64,033

Aura Announces Preliminary Q2 2025 Production Results GlobeNewswire July 03, 2025 ROAD TOWN, British Virgin Islands, July 03, 2025 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to announce Q2 2025 preliminary production results from the Company's operating mines: Aranzazu, Apoena, Minosa, Almas and

Bowling Green, July 03, 2025 (GLOBE NEWSWIRE) — Section 1 – Introduction In 2025, the discourse surrounding prescription weight loss treatments is gaining momentum, fueled by increasing public awareness of GLP-1 receptor agonists, such as semaglutide and tirzepatide. Developed initially as antidiabetic agents, these medications are now at the forefront of interest in physician-monitored, non-surgical

Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote

Chicago, Illinois, July 03, 2025 (GLOBE NEWSWIRE) — With a focus on simplicity and security, XRP Mining's new app empowers users worldwide to participate in crypto mining without technical complexity. This breakthrough solution removes traditional entry barriers, offering fast setup, stable returns, and 24/7 cloud-based performance–all from your smartphone. XRP Mining has officially launched a

Miami, FL, July 03, 2025 (GLOBE NEWSWIRE) — As the Federal Reserve slows its rate hikes and the global crypto market picks up, Bitcoin (BTC) has once again broken through a key price range, attracting more and more U.S. investors seeking a stable passive income method to participate in the growth of the crypto market.

Breaking Barriers: XRP Mining's Innovative App Opens Global Access to Secure Cloud Mining With a focus on simplicity and security, XRP Mining's new app empowers users worldwide to participate in crypto mining without technical complexity. This breakthrough solution removes traditional entry barriers, offering fast setup, stable returns, and 24/7 cloud-based performance–all from your smartphone. GlobeNewswire